EUVIMEDEUVIMED entdecken
CrossrefInfokarte

In vitro synergistic activity of minocycline and biapenem against cefiderocol-resistant New Delhi metallo-β-lactamase-producing Enterobacterales

Takashi Okanda, Niinyo Nakajima, Tetsuo Yamaguchi, Takuro Koshikawa, Tadatomo Oyanagi, Tomonori Takano, Hiroyuki Kunishima, Mitsuo Kaku, Hiromu Takemura

Journal of Antimicrobial Chemotherapy · 2026-04-03 · 81 (5)

DOI: 10.1093/jac/dkag128 ↗
AbstractBibliografische Angaben

Abstract

Abstract Objectives Cefiderocol is an important treatment option for infections caused by multidrug-resistant Gram-negative bacteria; however, resistance among New Delhi metallo-β-lactamase-producing Enterobacterales (NDME) is increasingly reported, leaving limited therapeutic alternatives. This study evaluated the in vitro activity of the minocycline–biapenem combination against cefiderocol-resistant NDME. Methods Twenty-three non-duplicate clinical NDME isolates with cefiderocol MIC ≥ 16 mg/L determined by reference broth microdilution in iron-depleted cation-adjusted Mueller–Hinton broth were analysed. Checkerboard assays were performed to assess combination activity using fractional inhibitory concentration indices (FICIs), sub-MIC interaction analysis and cumulative inhibition heatmaps. Time–kill assays were conducted using three representative isolates producing NDM-1 or NDM-5. Results Susceptibility rates for minocycline and biapenem tested alone were 52% and 13%, respectively. The minocycline–biapenem combination demonstrated synergistic activity (FICI ≤ 0.5) in 22 of 23 isolates (96%), with a median FICI of 0.063. Synergy was consistently observed across Escherichia coli, Enterobacter cloacae and Klebsiella pneumoniae. Sub-MIC analyses revealed asymmetric pharmacodynamic interactions, with sustained reductions in biapenem MIC at minocycline exposures as low as 1/512× baseline MIC. Cumulative inhibition heatmaps showed growth inhibition in 100% of isolates at the susceptible breakpoint concentrations of minocycline (4 mg/L) and biapenem (1 mg/L). Time–kill assays confirmed rapid and exposure-dependent bactericidal activity at clinically achievable concentration pairs. Conclusions The minocycline–biapenem combination showed consistent in vitro synergistic and bactericidal activity against cefiderocol-resistant NDME across multiple species and NDM variants. These findings support further pharmacodynamic and translational evaluation of this combination as a potential therapeutic option for cefiderocol-refractory infections.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →